Stephen Murray CCMP Capital was a private equity investor and an altruist. He was born in 1962, Brooklyn New York. He attended Sleepy Hollow High School, earned a degree in economics from Boston College and a master’s degree in business administration from Columbia Business School. He was president and CEO of Stephen Murray CCMP Capital, a private equity firm which focuses on acquisition and growth equity dealings. Prior to founding to CCMP Capital Advisors, he served in many investment capacities at its herald firms including Chase Capital Partners among others. As a philanthropist he supported the Make – A – Wish Foundation of Metro New York, Columbia business school, Stamford Museum, Boston College, the Food Bank of Lower Fairfield County among many others, but in the yes of the world, he soared and now survived by his wife Tami Murray and his four children.
CCMP Capital is a planetary private equity firm specializing in acquisition and growth equity dealings based in New York. It started operations as an independent firm in 2006. It leverages the combined strength of its ownership operating assets and phenomenon industry expertise to drive company growth and operational figure of merit. Its investment professionals continue to manage the private equity role of J.P. Morgan Partners. CCMP Capital has invested approximately twelve billion dollars in leveraged acquisition and growth capital dealings since inception. It was ranked number seven among world’s largest equity funds. It has over fifty employees with offices in New York, London, Hong Kong and Tokyo.
CCMP Capital has been known on Wall Street by several names over the past two decades. Originally as Chemical Venture Partners, as an arm of Chemical Bank. Later on the name changed to Chase Capital partners and yet to JP Morgan Partners following acquisition of J.P. Morgan & Co. and the formation of JPMorgan Chase. JPMorgan Chase acquired Bank One’s One Equity Partners. Later on, JP Morgan Partners separated from JPMorgan Chase and adopted the CCMP acronym in reference to its predecessor entities; Chemical and Chase and JP Morgan Partners. The spinout of CCMP was at such a time when there were other spinouts of other private equity groups of the same calibre, including Morgan Stanley, Citigroup among many others.
In 2014, CCMP Capital old Medpace- a pharmaceutical contract research to Cinven.
Following the spin out, JP Morgan partners made novel investments in leveraged acquisition, growth capital and venture capital dealings. Panorama Capital- a new firm was born out of the spin out.
CCMP Capital Asia made a formal separation from CCMP Capital changing its name to Unitas Capital. Linzor Capital is also among the notable spinouts from CCMP’s predecessor.